Abstract
Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2-11.0) months. Clinical success occurred in 9/12 (75.0%) patients. Three patients experienced a possible adverse effect while on therapy.
Original language | English (US) |
---|---|
Article number | ofab002 |
Journal | Open Forum Infectious Diseases |
Volume | 8 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2021 |
Keywords
- Mycobacterium abscessus
- omadacycline
- rapidly growing nontuberculous mycobacteria
ASJC Scopus subject areas
- Infectious Diseases
- Oncology